9 studies found for:    Open Studies | "Influenza in Birds"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Not yet recruiting A Safety and Immunogenicity Study of IVACFLU-A/H5N1
Condition: Avian Influenza
Interventions: Biological: A/H5N1 vaccine;   Biological: Placebo Comparator
2 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013;   Drug: MF59;   Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca
3 Recruiting Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old
Condition: Influenza A Virus, H7N9 Subtype
Interventions: Biological: H7N9 Anhui 2013/AA ca;   Biological: Inactivated subvirion H7N9 vaccine
4 Recruiting A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects
Condition: H7N9 Influenza Vaccine
Interventions: Biological: AT-501 High Dose vaccine;   Biological: AT-501 High Dose vaccine with Adjuvant;   Biological: AT-501 Low Dose vaccine;   Biological: AT-501 Low Dose vaccine with Adjuvant
5 Not yet recruiting H7N9 Boost in Healthy Adults
Condition: Influenza
Intervention: Biological: Monovalent influenza A/H7N9 virus vaccine
6 Recruiting Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
Conditions: Acute Lung Injury;   Acute Respiratory Distress Syndrome (ARDS);   Multiple Organ Failure
Intervention: Drug: Menstrual blood stem cells
7 Unknown  Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults
Condition: Pandemic Influenza
Intervention: Biological: Pandemic Influenza Vaccine (H5N1)
8 Not yet recruiting A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults
Condition: Influenza
Interventions: Biological: recombinant influenza hemagglutinin;   Biological: Advax1;   Biological: Advax2
9 Not yet recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age
Condition: Influenza
Interventions: Biological: Investigational H7N9 vaccine GSK3277510A;   Biological: Investigational H7N9 vaccine GSK3277509A;   Biological: Placebo

Indicates status has not been verified in more than two years